- Home
- NVNO vs LNZA Comparison
NVNO vs LNZA Comparison
Compare NVNO & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- LNZA
- Stock Information
- Founded
- NVNO 1987
- LNZA 2005
- Country
- NVNO United States
- LNZA United States
- Employees
- NVNO N/A
- LNZA N/A
- Industry
- NVNO Medical/Dental Instruments
- LNZA Major Chemicals
- Sector
- NVNO Health Care
- LNZA Industrials
- Exchange
- NVNO Nasdaq
- LNZA Nasdaq
- Market Cap
- NVNO 71.0M
- LNZA 65.7M
- IPO Year
- NVNO N/A
- LNZA N/A
- Fundamental
- Price
- NVNO $4.10
- LNZA $0.28
- Analyst Decision
- NVNO
- LNZA Hold
- Analyst Count
- NVNO 0
- LNZA 2
- Target Price
- NVNO N/A
- LNZA $2.00
- AVG Volume (30 Days)
- NVNO 145.2K
- LNZA 2.3M
- Earning Date
- NVNO 07-30-2025
- LNZA 08-07-2025
- Dividend Yield
- NVNO N/A
- LNZA N/A
- EPS Growth
- NVNO N/A
- LNZA N/A
- EPS
- NVNO N/A
- LNZA N/A
- Revenue
- NVNO N/A
- LNZA $48,831,000.00
- Revenue This Year
- NVNO N/A
- LNZA $58.17
- Revenue Next Year
- NVNO N/A
- LNZA $10.92
- P/E Ratio
- NVNO N/A
- LNZA N/A
- Revenue Growth
- NVNO N/A
- LNZA N/A
- 52 Week Low
- NVNO $2.03
- LNZA $0.14
- 52 Week High
- NVNO $6.48
- LNZA $2.74
- Technical
- Relative Strength Index (RSI)
- NVNO 51.11
- LNZA 50.36
- Support Level
- NVNO $3.90
- LNZA $0.25
- Resistance Level
- NVNO $4.06
- LNZA $0.33
- Average True Range (ATR)
- NVNO 0.26
- LNZA 0.04
- MACD
- NVNO -0.06
- LNZA -0.00
- Stochastic Oscillator
- NVNO 19.61
- LNZA 37.63
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.